Skip to main content

Peer Review reports

From: Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment

Original Submission
2 Mar 2004 Submitted Original manuscript
7 Jul 2004 Author responded Author comments - Gary Pakes
24 Mar 2004 Reviewed Reviewer Report - Leonardo Calza
2 Apr 2004 Reviewed Reviewer Report - Scott Penzak
Resubmission - Version 2
7 Jul 2004 Submitted Manuscript version 2
14 Jul 2004 Author responded Author comments - Gary Pakes
Resubmission - Version 3
14 Jul 2004 Submitted Manuscript version 3
12 Aug 2004 Author responded Author comments - Gary Pakes
Resubmission - Version 4
12 Aug 2004 Submitted Manuscript version 4
22 Oct 2004 Author responded Author comments - Gary Pakes
23 Aug 2004 Reviewed Reviewer Report - Leonardo Calza
18 Aug 2004 Reviewed Reviewer Report - Scott Penzak
Resubmission - Version 5
22 Oct 2004 Submitted Manuscript version 5
Publishing
12 Jan 2005 Editorially accepted
12 Jan 2005 Article published 10.1186/1471-2334-5-2

You can find further information about peer review here.

Back to article page